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Introduction: Diabetic foot is one of the most serious complications of diabe-
tes affecting about 15% of all diabetes patients, and it is the leading cause of non-
traumatic lower limb amputations. This study presents a sociodemographic and 
clinical characterization of patients with diabetic foot ulcer indicated for ampu-
tation surgery.
Methods: A cross-sectional study with 206 patients with type 2 diabetes and a 
diabetic foot ulcer indicated for amputation surgery. Patients were assessed on 
sociodemographic and clinical characteristics, pain intensity and pain interfer-
ence, after answering the Brief Pain Inventory, and on pain descriptors accord-
ing to the Douleur Neuropathique 4.
Results: Most patients were male, with little formal education and a mean age 
of 66 years. They had been diagnosed with type 2 diabetes for 18 years in aver-
age, and diagnosed with diabetic foot ulcer in average 3 years prior to the assess-
ment. About 59% of patients experienced pain in the lower limb that significant-
ly interfered with all areas of their functioning.
Conclusion: The social demographic variables play an important role in diabet-
ic foot ulceration. Given that the neuropathic ulcers are more easily preventable, 
systematic monitoring of patients with neuropathy is important. In patients 
with neuroischemic foot, strategies to cope or manage more efficiently the pain 
are paramount. Intervention should be multidisciplinary and take into account 
sociodemographic and clinical factors, as well as the presence, intensity and in-
terference of pain in the patient’s daily life activities and whether the patient has 
family or caregiver support.
Keywords: type 2 diabetes mellitus, diabetes complications, diabetic foot.
IntroductIon
Around 13% of the Portuguese population has diabetes, 
which corresponds to an estimated 1 million individuals, 
aged between 20 and 79 years.1
Diabetes is a complex chronic disease that requires 
regular medical follow-up.2 Diabetes care involves a change 
in lifestyle (healthy eating, physical activity, stopping 
smoking, weight control and effective problem-solving 
strategies), self-management of the disease (adherence to 
the medication, self-monitoring of blood glucose) and 
the prevention of complications (adherence to foot care 
and screening for vision and kidney problems).2
The persistence of a high level of glucose in the blood 
results in tissue damage. These lesions may be found in 
various organs but their manifestation at the level of the 
kidneys, eyes, nerves and peripheral vascular system are 
the most important.1 The main complications of diabe-
tes are diabetic retinopathy, diabetic neuropathy, nephrop-
athy and atherosclerotic vascular diseases such as periph-
eral vascular disease (PVD), coronary heart disease and 
cerebrovascular disease.3
Diabetic foot ulcer (DFU) is a term used to designate 
lesions that can occur in a diabetes patient’s foot. It has a 
neuropathic etiopathogenic basis, caused by chronic hy-
perglycemia which, in the absence or presence of PVD, and 
due to prior trauma in the foot, causes ulceration. This 
problem represents one of the most serious complications 
of diabetes, affecting approximately 15% of all diabetic in-
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dividuals, and constitutes the leading cause of non-trau-
matic amputation of lower limbs.4 At least 15% of DFU pa-
tients will suffer an amputation of the thigh or leg. The 
risk of a patient with diabetes developing a foot ulcer 
throughout life can reach 25%, and it is known that every 
30 seconds a lower limb amputation, caused by diabetes, 
occurs worldwide.6 Therefore, DFU is considered one of 
the complications of diabetes that result in higher costs 
given that the final solution is often an amputation.5
Therefore, there are two types of diabetic foot: the 
neuropathic diabetic foot caused by diabetic polyneurop-
athy, and the neuroischemic diabetic foot caused by ar-
terial occlusion that is, in most cases, associated to the 
neuropathy. Diabetic foot lesions arise due to insensitiv-
ity caused by sensory/motor neuropathy and/or ischemia 
caused by atherosclerotic lesions in the lower limb. Pref-
erential impairment of one of these two structures, nerves 
or blood vessels, will condition the appearance of a neu-
ropathic or neuroischemic foot.6,8
Regarding the etiology of ulcers and diabetic foot 
type, the literature suggests a greater prevalence of neu-
roischemic ulcers ranging between 59 and 74%. The prev-
alence of neuropathic ulcers has been falling, ranging 
from 26 to 45%.7,9,10
The presence of an ulcer has serious emotional, so-
cial and economic implications,11,12 decreasing consider-
ably the patient’s mobility, autonomy, and quality of 
life.13,15 In addition, ulcers can be a source of pain, also 
contributing to progressive degradation of the diabetic 
patient’s quality of life.16,17 In the presence of the most se-
vere form of PVD, trophic lesions may appear, such as 
ischemic ulcers and necrosis of the toes, responsible for 
the worsening of pain, which may already be present due 
to the disease itself.18,20 In the neuroischemic foot, the 
pain due to ischemia can be intense but due to the effects 
of diabetic neuropathy, may also be less dramatic (or even 
absent).18 Neuropathic pain is described as something 
that bothers an individual, not necessarily a very strong 
pain, even though, in some cases, the symptoms of pain 
can be intense.21 Patients usually describe the pain as “pins 
and needles”, “tingling” or “burning”.22,23
Therefore, the presence of either PVD or painful neu-
ropathy, or both, can contribute to the presence of pain 
and considerably diminish the quality of life of diabetic 
patients.24 According to the existing studies, neuropath-
ic pain is associated with a lower quality of life,22 high lev-
els of anxiety and depression, as well as impaired sleep.25,26 
Furthermore, neuropathic pain causes disability and 1/3 
of patients need help to walk (crutches or wheelchair).27,28 
There are several pharmacological and non-pharmaco-
logical interventions,29 whose main goal is the manage-
ment and reduction of pain as well as the promotion of 
a satisfactory general functioning, in the patient.30
The goes of this study were the following: 1) to pro-
vide a sociodemographic and clinical characterization of 
a sample of patients with DFU indicated for amputation 
surgery 2) to characterize the pain in terms of intensity 
and interference in daily life activities, and 3) to under-
stand the relationships between the intensity and inter-
ference of pain and sociodemographic and clinical vari-
ables. Lastly, with this study we hope to gain knowledge 
regarding the demographic, social and clinical character-
istics of patients with DFU as well as the prevalence of 
pain, its intensity and interference in patient’s daily life 
activities in order to develop appropriate and effective 
multidisciplinary interventions.
methodS
This study was conducted at the Diabetic Foot Clinic of five 
hospitals and two Vascular Surgery Departments in the 
north of Portugal, in order to characterize patients with type 
2 diabetes and diabetic foot referred for amputation surgery. 
The study was conducted in the period between June 2013 
and June 2015.
This was a longitudinal study, but in the present pa-
per we are only presenting data from the first evaluation, 
i.e. data relating to patients at the time of hospitalization 
due to DFU. The clinical data was obtained from health 
professionals’ charts. The criteria for inclusion in the sam-
ple was: having type 2 diabetes and diabetic foot ulcer; 
being referred for an amputation surgery; being older 
than 18 years; showing auto- and allopsychic orientation; 
having the ability to interpret and answer orally and not 
having a diagnosis of severe psychiatric pathology (e.g. 
psychosis). The study was approved by the Ethics Com-
mittee of the six hospitals.
The instruments used were:
 • Sociodemographic and clinical questionnaire: This 
questionnaire took into consideration demographic, 
social and patients’ clinical data.
 • Brief pain inventory:31,32 The BPI consists of 15 items 
assessing the presence, location, intensity, and interfe-
rence of pain, therapeutic strategies used and effecti-
veness of the pain treatment. It includes two subscales: 
one assessing intensity of pain consisting of 4 items 
(maximum, minimum, average and current pain), and 
another assessing the interference of pain consisting 
of 7 items (general activity, mood, walking ability/mo-
bility, normal work (outside the home and housework/
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DLAs), relations with others, sleep, enjoyment of life), 
in a numeric rating scale (NRS) (from 0 to 10 with 0=no 
interference and 10=interferes completely). High re-
sults indicate greater severity of pain and greater inter-
ference of pain. A score of 3 is considered the cutoff 
score indicating significant pain.33-35 The scale asses-
sing intensity of pain showed an alpha of .82 while the 
interference assessment scale presented an alpha of .89.
 • Douleur Neuropathique 4 (DN4) questionnaire:36,37 
Consisting of 10 items, comprises two questions about 
pain (corresponding to seven items) and two tests of 
cutaneous sensitivity (corresponding to three items). 
In this study, only the two questions about pain, com-
prising seven items, that include the following signs 
and descriptors of neuropathic pain were used: “The 
pain presents itself in this way”: Burning, sensation 
of painful cold, electric shocks; and “in the same re-
gion as the pain, one or more of the following symp-
toms is also felt”: Tingling, pins and needles, num-
bless and itching. This questionnaire was used to 
characterize the pain and was not included in the in-
ferential statistical analysis.
The data analysis included descriptive statistics to char-
acterize the sample in terms of sociodemographic and 
clinical variables. A Pearson correlation was performed 
to assess the relationships between interval variables and 
a Point Bisserial correlation to analyze relationships be-
tween dichotomous variables.
reSultS
Sociodemographic characteristics of the sample
The 206 patients were hospitalized due to a diabetic foot ul-
cer and were referred for amputation surgery. 72.3% (n=149) 
were male, with an average age of 66.1 (SD=10.88%) years, 
the youngest patient was 36 and the oldest 90 years old, and 
presented 4.55 years (SD=3.14) of formal education. About 
63% of the sample was married, with 76.8% (n=156) being 
retired, while the remaining were still professionally active. 
Almost all patients reported having a caregiver (n=178, 86.4%), 
most often the spouse (50%, n=103) followed by their off-
spring (24.3%, n=50).
In terms of mobility, 37.9% (n=78) of the sample re-
ported having used crutches for daily activities, on aver-
age, for 17 months (SD=43.1), 12.1% (n=25) had used a 
wheelchair, on average for 15 months (SD=15.8), and only 
2.9% (n=6) were bedridden, for 11 months on average 
(SD=13.5).
As for access to primary health care, 94.2% of partic-
ipants (n=194) reported having a family physician, 65.5% 
(n=135), had attended 4 annual consultations at their 
health care center in the previous year, and 62% (n=128) 
underwent monitoring at a Diabetic Foot Clinic, mainly 
in the hospital of their area of residence (40.6%, n=52) or 
the health care center (59.4%, n=76).
Clinical characteristics of the sample
Patients presented a diagnosis of type 2 diabetes for an 
average of 18 years (SD=11.56) ranging between 1 month 
and 53 years and a diagnosis of diabetic foot on average 
for 4 years (SD=4.59) ranging between 1 month and 22 
years. One hundred forty two (68.9%) patients were treat-
ed with insulin and 85 (41.3%) had already been hospi-
talized in the previous year due to DFU. Regarding the 
type of foot, 26.2% presented a neuropathic foot and 73.8% 
a neuroischemic foot. The remaining clinical character-
istics of the sample are presented in Table 1.
TABLE 1 Clinical characteristics of the sample.
Foot type Neuropathic 26.2
Neuroischemic 73.8%
Complications from diabetes Yes 99.5%
Nephropathy 49.5%
Retinopathy 65%
Neuropathy 97.1%
Macrovascular disease 83.5%
Other chronic diseases Yes 24.3%
No 75.7%
Risk factors for cardiovascular 
disease
Yes 93.7%
Dyslipidemia 77.7%
High blood pressure 86.4%
Currently smoker 7.3%
Smoking history 51%
Alcohol consumption 31.1%
BMI: healthy weight 29.6%
Excess weight 47.6%
Obesity 16%
Metabolic control <7.5% 29.8%
>7.6% 70.2%
Location of the ulcer Leg 4.9%
Foot 29.1%
Heel 2.9%
Toes 63.1%
Duration of the ulcer Up to 6 weeks 42.2%
Up to 6 months 34.5%
More than 6 months 12.6%
More than 1 year 10.7%
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Characterization of the pain
From the total sample, 58.7% (n=121) of patients presented 
pain in the lower limb. In relation to the descriptors of neu-
ropathic pain, the descriptor “pins and needles” was the 
most reported followed by “burning” and “numbness” pain, 
with each patient referring to the three neuropathic pain de-
scriptors on average (SD=1.2). Almost all patients who felt 
pain mentioned taking pain medication at home (94.2%, 
n=114), especially acetaminophen (32.5%), the combination 
of acetaminophen and opioids (27.5%) and 7.9% gabapenti-
noids. Nearly half of patients (49.6%) reported that the pain 
medication provided relief between 50 to 100%, while the 
remaining 50.4% indicated lower scores for pain relief.
Patients report pain mainly in the foot (65.3%, n=79) for 
23 weeks on average (SD=21.9), ranging from 1 to 96 weeks. 
About 36% of patients (n=43) reported pain elsewhere. The 
pain often was reported as having a daily frequency (51.2%, 
n=62), followed by constant pain (42.1%, n=51). About 36% 
of patients (n=43) reported pain elsewhere.
As for the intensity of the pain, in the last week, the av-
erage of the maximum intensity was above 3 (considered 
the cutoff score for significant pain) and the minimal pain 
(scores of 1 or 2) was still indicative of non-absence pain 
in patients (Figure 1). Similarly, for the level of interfer-
ence of pain the results showed that all areas were impact-
ed showing significant scores (above 3) and, therefore, im-
paired (Figure 2).
Relationship between intensity/interference of pain and clinical 
and sociodemographic variables
Intensity of pain was positively related with age (r=.292, 
p=<.01), pain duration (r=.230, p=>.05) and ulcer dura-
tion (r=.210, p<.05). Interference of pain was positively 
related with age (r=.183, p<.05) and number of hospital-
izations in the last year (r=.240, p<.01) and negatively with 
type of foot (r=-.250, p<.01), i.e. patients with neuropath-
ic foot showed less interference of pain.
dIScuSSIon
There are several studies that suggest that the sociodemo-
graphic variables play an important role in diabetic foot 
ulceration and not just the clinical factors.38-41 In the study 
by DeBerardis et al.39 the prevalence of diabetic foot com-
plications was higher in older patients, those with limited 
formal education and a low sociodemographic status, di-
vorced or widowed with greater duration of diabetes, high 
HbA1c, treated with insulin, and with micro and macro-
vascular complications. Our results do, in fact, corrobo-
rate the existing literature suggesting that diabetic foot ul-
cers in patients, scheduled for amputation, are more 
prevalent in males (occurring twice in men than wom-
en).11-41 However, it is important to take in consideration 
that the youngest patient was 39 years old and the mean 
age was 66 years old, indicating that half the sample was 
67 years old (median) or less, revealing a relatively young 
sample. This sample was characterized by a low education 
level, with most of the patients presenting five years of for-
mal education (elementary school), which may hinder the 
understanding of the information provided by health pro-
fessionals and, therefore, impact adherence to self-care be-
haviors.17 More than half of the sample was retired (due to 
age or disability), while about 23% were still active. Profes-
sional inactivity is considered a risk factor for diabetic foot 
ulceration38,42 and the percentage of patients still employed 
highlights the negative impact that DFU may have at per-
sonal and financial levels. In fact, DFU recovery may lead 
to unemployment, prolonged medical leave and econom-
ic costs to the patient and the family.7
FIGURE 1 Mean of pain intensity.
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FIGURE 2 Mean of pain interference.
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Regarding marital status, almost all patients were married 
and the main caregiver reported was the patient’s spouse 
or the offspring. This fact shows the importance of the role 
of the family, that seem to be responsible to help the pa-
tient take care of his/her feet, especially when presenting 
diabetes complications that allow hinder foot daily self-
care behaviors (e.g. retinopathy) or other chronic diseases 
that affect adherence to self-care behaviors, such as cogni-
tive deficits. A study by Macfarlane and Jeffcoate43 empha-
sized the importance of patient and family education in 
foot self-care, as only 56% of the lesions were detected by 
the patients themselves. Taking into account the role of 
the family in the patient’s adherence to self-care and the 
detection of lesions, the Governmental Norm of the Na-
tional Portuguese Health System – 5/PNPCD44 stated that 
patients and families’ education regarding foot care was a 
priority in order to prevent the emergence of new ulcers, 
as well as to manage the seriousness of the current clinical 
symptoms.
This sample of patients presented a functional mobil-
ity level, if we take into account that they all had lower limb 
ulcers and had been referred for amputation surgery. While 
about 38% of the sample needed crutches to move, only 
12% needed a wheelchair, and only six patients were bed-
ridden and, therefore, dependent on the care of significant 
others. Studies have been reporting that foot ulcers can 
cause serious disability, decreased mobility and long peri-
ods of hospitalization, and are, therefore, considered an 
economic burden for families and the health system.45,46
As for access to primary health care, almost the en-
tire sample reported having a family physician although 
only half of the participants reported attending four an-
nual consultations at the health center. Fortunately, more 
than half of the participants mentioned being monitored 
by a Diabetic Foot Clinic, at the hospital, since they are 
at high-risk for amputation and monitoring is no longer 
undertaken at primary health care services, but by mul-
tidisciplinary teams in hospitals. However, there are sev-
eral factors that influence the degree to which the patient 
is capable of performing self-care, such as personal health, 
access to health care, education about foot care and for-
mal and informal support.47 Unfortunately, foot care 
seems to be the least performed self-care in diabetes.39,48
With regard to the characteristics of diabetes, patients 
presented the disease for an average of 18 years and dia-
betic foot for an average of 4 years. Given the long dura-
tion of diabetes, it is understandable that the sample pre-
sented complications from diabetes, with the most 
prevalent being diabetic neuropathy and macrovascular 
complications such as cardiovascular, cerebral and pe-
ripheral vascular disease.38,42,49
In this sample, neuroischemic foot had a higher prev-
alence than neuropathic foot, as recent studies have also 
reported.7,9,10 The change in the prevalence of ulcers may 
be due to patients’ age, given that, as they get older, they 
develop more complications from diabetes. Also, the ma-
jority of patients have ulcers in the lower limbs that have 
developed in a period of 1 to 6 weeks, predominantly in 
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the toes followed by the foot. This location is more subject 
to ordinary trauma in the everyday life, and is anatomical-
ly more susceptible to the development of tissue necrosis.
More than half of the sample reported pain and most 
reported pain descriptors were “pins and needless”, “burn-
ing” and “numbness”. These descriptors are common in 
the description of neuropathic pain.22,23,27 The literature 
indicates that the pain is associated with a poor quality 
of life22 with consequences in terms of quality of sleep, 
psychological morbidity and mobility impairments.25,27 
In fact, the impact of pain on patient functioning is evi-
dent and, in this study, the maximum intensity of pain 
reported by patients was significant and the minimal pain 
reported was also indicative that patients lived daily with 
non-absence pain. Regarding interference, the pain sig-
nificantly interfered with all functional areas of life. Only 
the item that assessed enjoyment of life was above the 
cutoff score of 3. Also, almost half of the sample of pa-
tients with pain reported that analgesic medication re-
lieved between 50 and 100% of the pain, which indicates 
some effectiveness of medication on pain management, 
even though the remaining of the sample reported low-
er relief. The pain medication recorded in this study in-
cludes the medication that patients usually take at home, 
prescribed by their doctors, and not the medication ad-
ministered during the period of hospitalization which, 
understandably, has a higher efficacy. Jensen et al.50 re-
port that only 1/3 of patients report 50% of pain relief 
from medication. However if the treatment for pain causes 
at least 30% of relief, it is considered effective.51
We found that the oldest patients with a longer du-
ration of ulcer and pain presented a higher intensity of 
pain. Patients with more number of hospitalizations and 
with a neuroischemic foot reported higher interference 
of pain, as expected.
The prevention of ulcers requires a strict metabolic 
control, good adjustment to chronic illness in general, 
and especially regular and consistent feet inspection.38 
However, most of the interventions that have been per-
formed, in this population, include only the provision of 
information and behavioral skills training, without tak-
ing into account the psychosocial process underlying foot 
care adherence52 in the patient and the family support.43
This study has some limitations such as the use of self 
report measures and the sample size regarding the num-
ber of patients with neuropathic foot. In the future it would 
be important to assess the interference and intensity of 
pain after surgery and during the rehabilitation process in 
order to promote DFU patients’ quality of life.
concluSIon
The results of this study corroborate international stud-
ies to the extent that this sample of DFU patients does 
not differ from international samples, highlighting the 
homogeneity of the social, demographic, and clinical char-
acteristics that characterize this population.
According to the results, this study emphasizes the 
need for prevention regarding foot care as well as the need 
for intervention in patients that are already diagnosed with 
DFU, particularly those that report pain. As such, in DFU 
patients should be the target of systematic multidisciplinary 
interventions, that focuses on the regular assessment of 
adherence to the recommended self-care behaviors and 
take also into consideration whether the patient receives 
support from a caregiver or family member. The need for 
psychological monitoring should also be considered when 
the interference of pain on DLAs is high and the patient 
has no family support, in order to promote pain coping 
strategies that foster psychological wellbeing.
Pain, in DFU patients, is a specific health problem with 
unique characteristics. It is therefore urgent to identify pa-
tients who report pain and intervene preventively before it 
becomes chronic associated with amputation. The inter-
vention should be multidisciplinary and involve all the 
health professionals who can provide pain management, 
including the family member or the patient’s caregiver.
The literature has been suggesting that the risk of 
foot complications can be reduced by 49 to 85% through 
preventive measures, patient education, and foot self-care 
behaviors, with structured diabetes health care consulta-
tions being the most promising measure to reduce am-
putation (major) in patients with diabetes.53-55
The psychological wellbeing of the patient plays an 
important role in the management of the disease and in 
adherence to self-care, in diabetes. The literature has shown 
that individual and family psychological variables as well 
as health system variables play a major role in adherence 
to self-care.56-58 For this reason, health professionals who 
deal with DFU patients should take into account the pa-
tient’s biopsychosocial context. The psychosocial prob-
lems that patients present need to be addressed since they 
may compromise the adherence to self- care behaviors 
and hinder the process of adjustment to amputation.
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reSumo
Características sociodemográficas e clínicas de doentes 
com pé diabético 
Introdução: o pé diabético é uma das complicações mais 
graves da diabetes, afetando cerca de 15% dos indivíduos 
com diabetes, e é a maior causa de amputação de mem-
bros inferiores de origem não traumática. Este estudo 
apresenta uma caracterização sociodemográfica e clínica 
de doentes com pé diabético indicados para cirurgia de 
amputação. 
Método: estudo transversal com 206 doentes com diabe-
tes tipo 2 e pé diabético indicados para cirurgia de am-
putação. Foram recolhidos dados sociodemográficos e 
clínicos. Intensidade e interferência da dor foram avalia-
das por meio do Brief Pain Inventory e os descritores da 
dor, pelo Douleur Neuropathique 4.
Resultados: a maioria dos doentes era do sexo masculino, 
com baixa escolaridade e uma média de idade de 66 anos. 
Apresentava diagnóstico de diabetes tipo 2 havia 18 anos 
e pé diabético havia 4 anos. Cerca de 59% dos doentes apre-
sentavam dor no membro inferior, interferindo significa-
tivamente em todas as áreas de funcionamento.
Conclusão: as variáveis sociodemográficas desempenham 
um papel importante na ulceração do pé diabético. As úl-
ceras neuropáticas são mais facilmente preveníveis; por-
tanto, é importante o acompanhamento sistemático dos 
doentes com neuropatia. Nos doentes com pé neurois-
quêmico, estratégias para lidar/gerir a dor de forma mais 
eficaz são necessárias. A intervenção deve ser multidisci-
plinar e considerar os fatores sociodemográficos e clíni-
cos, a presença, intensidade e interferência da dor nas ati-
vidades de vida diária do doente, bem como a presença 
de suporte da família ou de um cuidador.
Palavras-chave: diabetes mellitus tipo 2, complicações do 
diabetes, pé diabético.
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in the lower limb that significantly interfered with all areas of their functioning.”
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